These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21328430)

  • 1. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study.
    Castillo JJ; Beltran BE; Bibas M; Bower M; Collins JA; Cwynarski K; Diez-Martin JL; Hernandez-Ilizaliturri F; Horwitz SM; Montoto S; Pantanowitz L; Ribera JM; Vose JM
    Am J Hematol; 2011 Mar; 86(3):256-61. PubMed ID: 21328430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
    J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS.
    Boulanger E; Gérard L; Gabarre J; Molina JM; Rapp C; Abino JF; Cadranel J; Chevret S; Oksenhendler E
    J Clin Oncol; 2005 Jul; 23(19):4372-80. PubMed ID: 15994147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi.
    Morabito F; Gallamini A; Stelitano C; Callea V; Guglielmi C; Neri S; Lazzaro A; Orsucci L; Ilariucci F; Sacchi S; Vitolo U; Federico M
    Cancer; 2004 Oct; 101(7):1601-8. PubMed ID: 15378507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.
    Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M
    Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome.
    Tedeschi R; Bortolin MT; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
    J Clin Virol; 2012 Apr; 53(4):297-301. PubMed ID: 22244256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.
    Mak V; Hamm J; Chhanabhai M; Shenkier T; Klasa R; Sehn LH; Villa D; Gascoyne RD; Connors JM; Savage KJ
    J Clin Oncol; 2013 Jun; 31(16):1970-6. PubMed ID: 23610113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.
    Amara S; Dezube BJ; Cooley TP; Pantanowitz L; Aboulafia DM
    Clin Infect Dis; 2006 Nov; 43(9):1198-205. PubMed ID: 17029142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T-cell lymphoma in HIV-infected patients: a study of 17 cases in the combination antiretroviral therapy era.
    Gilardin L; Copie-Bergman C; Galicier L; Meignin V; Brière J; Timsit JF; Bouchaud O; Gaulard P; Oksenhendler E; Gérard L
    Br J Haematol; 2013 Jun; 161(6):843-51. PubMed ID: 23593987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
    Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
    Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome.
    Zaja F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Salmaso F; Mariuzzi L; Di Loreto C; Baccarani M
    Haematologica; 1997; 82(2):171-7. PubMed ID: 9175321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
    Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
    Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.
    Castillo J; Pantanowitz L; Dezube BJ
    Am J Hematol; 2008 Oct; 83(10):804-9. PubMed ID: 18756521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.
    Toulson AR; Harrigan R; Heath K; Yip B; Brumme ZL; Harris M; Hogg RS; Montaner JS
    J Infect Dis; 2005 Nov; 192(10):1787-93. PubMed ID: 16235178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
    Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.